Enanta Pharmaceuticals stock trades at USD 12.11

Published on 09/23/2026 at 04:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Enanta Pharmaceuticals stock traded at USD 12.11 on September 22, 2026, with a 0.74 percent decline. The latest market data also show its average volume.

ENTA, US29251M1062, Illustration mit AI erstellt.

Enanta Pharmaceuticals, Inc. stock (ISIN US29251M1062) traded at USD 12.11 on Nasdaq on September 22, 2026, down 0.74 percent from the previous close, according to Yahoo Finance market data. The quoted move provides the clearest dated market reference for the company in the latest available trading information.

Stock data set the reference point

The September 22, 2026 quotation places Enanta Pharmaceuticals in the small-cap biotechnology segment, where daily price changes can remain sensitive to clinical and licensing developments. Yahoo Finance lists average volume of 499,363 shares in the same market-data snapshot, giving investors a concrete measure of recent trading activity.

The 0.74 percent decline is a quantified comparison with the previous close, while the USD 12.11 level is the primary Nasdaq reference price used here. The available quotation does not establish a reason for that session's move, so the article does not attribute the change to an unverified company event.

Biotech valuation remains data dependent

Enanta's investment case is tied to research programs and potential commercial milestones rather than a broad industrial revenue base. For that reason, operating updates, trial results, licensing income and cash resources are the figures that can change the market's assessment when they are reported for a defined period.

The latest dated market snapshot identifies Enanta Pharmaceuticals as ENTA and records a market capitalization of USD 436.878 million for Prothena Corporation plc on the referenced page, but that capitalization belongs to Prothena rather than Enanta and is therefore excluded from this article. The ENTA quotation itself remains the usable market figure from the page.

ENTA reference price is USD 12.11

Enanta Pharmaceuticals stock was quoted at USD 12.11 on Nasdaq on September 22, 2026, with a daily change of minus 0.74 percent. The fact box below repeats the same venue and date so the market reference remains consistent.